Evidence map›Paper›PMID 36422983›Full record

Observational studyToxins2022

Post Hoc Subgroup Analysis of the BCause Study Assessing the Effect of AbobotulinumtoxinA on Post-Stroke Shoulder Pain in Adults.

Marcelo Riberto, João Amaury Frances, Regina Chueire, Ana Cristina Ferreira Garcia Amorim, Denise Xerez, Tae Mo Chung, Lucia Helena Costa Mercuri, Sérgio Lianza, Eduardo Carvalho de Melo Rocha, Pascal Maisonobe and 2 more

Registry-linked trialOpen access · goldAbstract readMulticenter StudyObservational Study
PubMed Full text at PMC Publisher
In one paragraph

Observational study in Toxins, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02390206 (An Observational, Prospective, Multicentre, National Trial on the Benefit of Botulinum Toxin Type A), which is not on this map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02390206 completednot on this map

An Observational, Prospective, Multicentre, National Trial on the Benefit of Botulinum Toxin Type A (BoNT-A) Injections in Untreated Chronic Post-stroke Spastic Brazilian Patients

TypeobservationalSponsorIpsenRan2015 to 2017Enrolled239ConditionsSpasticity
3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Observational
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 10 institutions in 2 countries.

Marcelo RibertoFaculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, São Paulo 14049-900, Brazil.ORCID 0000-0001-9549-8830
João Amaury FrancesHospital Bettina Ferro de Souza, Campus IV da Universidade Federal do Pará, Belém 66075-110, Brazil.
Regina ChueireFaculdade de Medicina de São José do Rio Preto, Autarquia Estadual 15090-000, Brazil.
Ana Cristina Ferreira Garcia AmorimCentro de Reabilitação e Readaptação Dr. Henrique Santillo (CRER), Goiânia 74653-230, Brazil.ORCID 0000-0003-2234-0850
Denise XerezServiço de Medicina Física e Reabilitação, Hospital Universitário Clementino Fraga Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-590, Brazil.
Tae Mo ChungComplexo Hospital das Clinicas, Instituto de Medicina Fisica e Reabilitação, São Paulo 04116-030, Brazil.
Lucia Helena Costa MercuriHospital São Paulo-UNIFESP, São Paulo 04024-002, Brazil.
Sérgio LianzaHospital Alemão Oswaldo Cruz, São Paulo 01323-020, Brazil.
Eduardo Carvalho de Melo RochaServiço de Reabilitação da Irmandade da Santa Casa de Misericórdia de São Paulo, São Paulo 01221-010, Brazil.ORCID 0000-0003-2078-5450
Pascal MaisonobeIpsen, 92100 Boulogne Billancourt, France.
Thais Cuperman-PohlIpsen, São Paulo 04571-010, Brazil.
Patricia KhanCentro Catarinense de Reabilitação, Florianópolis, Santa Catarina 88025-301, Brazil.
Faculdade de Medicina de São José do Rio Preto · BRFundação de Amparo à Pesquisa e Inovação do Estado de Santa Catarina · BRHospital Alemão Oswaldo Cruz · BRHospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo · BRHospital São Paulo · BRIpsen (France) · FRIrmandade da Santa Casa de Misericórdia de São Paulo · BRUniversidade de São Paulo · BRUniversidade Federal do Pará · BRUniversidade Federal do Rio de Janeiro · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Botulinum toxin type A is approved for the focal treatment of spasticity; however, the effectiveness of abobotulinumtoxinA (aboBoNT-A) in patients with shoulder pain who have set reduced pain as a treatment goal is understudied. In addition, some patients encounter delays in accessing treatment programs; therefore, the suitability of aboBoNT-A for pain reduction in this population requires investigation. These factors were assessed in aboBoNT-A-naive Brazilian patients in a post hoc analysis of data from BCause, an observational, multicenter, prospective study (NCT02390206). Patients (N = 49,

Indexed as

Botulinum Toxins, Type AShoulderAgedFemaleHumansMaleMiddle AgedMuscle SpasticityProspective StudiesShoulder PainabobotulinumtoxinABotulinum Toxins, Type AabobotulinumtoxinApatientspost-strokeshoulder painspasticitytherapeutic goal

Identifiers

PMID36422983
PMCPMC9692702
OpenAlexW4309703475

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.